In July 2018 Burton Hospitals NHS Foundation Trust was part of a merger with Derby Hospitals NHS Foundation Trust, which created the University Hospitals of Derby and Burton NHS Foundation Trust and Burton Hospitals NHS Foundation Trust ceased to exist.

During the past decade, Queen's Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen's Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 4 trials, followed by "University College, London" with 4 trials sponsored, "Medical Research Council" with 3 trials sponsored, "University Hospital Southampton NHS Foundation Trust" with 3 trials sponsored and "University of Leeds" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen's Hospital" #1 collaborator was "Cancer Research UK" with 5 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Celgene" with 2 trials as a collaborator, "Takeda" with 2 trials as a collaborator and "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Queen's Hospital" are "Ovarian Cancer" (5 trials), "Breast Cancer" (4 trials), "Colorectal Cancer" (4 trials), "Fallopian Tube Cancer" (4 trials) and "Prostate Cancer" (4 trials). Many other conditions were trialed in "Queen's Hospital" in a lesser frequency.

Most popular intervention types in "Queen's Hospital" are "Drug" (34 trials), "Procedure" (12 trials), "Other" (9 trials), "Biological" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (5 trials), "carboplatin" (4 trials), "quality-of-life assessment" (4 trials), "capecitabine" (3 trials) and "cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Queen's Hospital" are 31 trials for "All" genders, 7 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Queen's Hospital". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Queen's Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Queen's Hospital, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".